(Q44051678)

29 November 2017

title

Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes (English)

1 reference

29 November 2017

0 references

1 reference

H N Buch

1

1 reference

29 November 2017

V Baskar

2

1 reference

29 November 2017

D M Barton

3

1 reference

29 November 2017

D Kamalakannan

4

1 reference

29 November 2017

C Akarca

5

1 reference

29 November 2017

B M Singh

6

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

19

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

572-574

1 reference

Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

Thiazolidinediones: a new class of antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

Trp64Arg mutation of beta3-adrenoceptor gene deteriorates lipolysis induced by beta3-adrenoceptor agonist in human omental adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

Lessons from the glitazones: a story of drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2002.00734.X

10.1046/J.1464-5491.2002.00734.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference